Search Results - "Vanderhoof, John"

Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses by Roeder, Alexa J, Koehler, Megan A, Jasbi, Paniz, McKechnie, Davis, Vanderhoof, John, Edwards, Baylee A, Gonzalez-Moa, Maria J, Seit-Nebi, Alim, Svarovsky, Sergei A, Lake, Douglas F

“…COVID-19 mRNA vaccines protect against severe disease and hospitalization. Neutralizing antibodies (NAbs) are a first-line defense mechanism, but protective…”
Get full text

Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders by Lake, Douglas F., Roeder, Alexa J., Gonzalez-Moa, Maria J., Koehler, Megan, Kaleta, Erin, Jasbi, Paniz, Vanderhoof, John, McKechnie, Davis, Forman, Jack, Edwards, Baylee A., Seit-Nebi, Alim, Svarovsky, Sergei

“…Background While evaluating COVID-19 vaccine responses using a rapid neutralizing antibody (NAb) test, we observed that 25% of mRNA vaccine recipients did not…”
Get full text

Successful repair of the long thoracic nerve after complete transection during axillary lymph node dissection by Agee, Neal, Bouton, Marcia E, Vanderhoof, John W

Get more information

Olsalazine Versus Sulfasalazine in Mild to Moderate Childhood Ulcerative Colitis: Results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial by Ferry, George D, Kirschner, Barbara S, Grand, Richard J, Issenman, Robert M, Griffiths, Anne M, Vanderhoof, John A, Fiedorek, Stephen C, Winter, Harland S, Hassall, Eric G, Watkins, John B, Gryboski, Joyce, Ulshen, Martin H, Daum, Frederic, Perman, Jay A, Thomas, Daniel W, Heubi, James E, Byrne, William J, Jones, Bobbette

“…SUMMARYThe safety and efficacy of olsalazine sodium was compared to sulfasalazine over 3 months in a multi-center, randomized, double-blind study of 56…”
Get full text

Olsalazine Versus Sulfasalazine in Mild to Moderate Childhood Ulcerative Colitis: Results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial by Ferry, George D., Kirschner, Barbara S., Grand, Richard J., Issenman, Robert M., Griffiths, Anne M., Vanderhoof, John A., Fiedorek, Stephen C., Winter, Harland S., Hassall, Eric G., Watkins, John B., Gryboski, Joyce, Ulshen, Martin H., Daum, Frederic, Perman, Jay A., Thomas, Daniel W., Heubi, James E., Byrne, William J., Jones, Bobbette

Get full text

Olsalazine Versus Sulfasalazine in Mild to Moderate Childhood Ulcerative Colitis by Ferry, George D., Kirschner, Barbara S., Grand, Richard J., Issenman, Robert M., Griffiths, Anne M., Vanderhoof, John A., Fiedorek, Stephen C., Winter, Harland S., Hassall, Eric G., Watkins, John B., Gryboski, Joyce, Ulshen, Martin H., Daum, Frederic, Perman, Jay A., Thomas, Daniel W., Heubi, James E., Byrne, William J., Jones, Bobbette

“…Summary The safety and efficacy of olsalazine sodium was compared to sulfasalazine over 3 months in a multi‐center, randomized, double‐blind study of 56…”
Get full text